NCT03722199View on ClinicalTrials.gov

Effects of Flavanoids in Essential Hypertension, Type 2 Diabetes and Healthy Persons

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

March 20, 2021

Study Completion Date

March 20, 2021

Conditions
Vascular Complications, Diabetic
Interventions
DIETARY_SUPPLEMENT

flavanols (subgroup of polyphenols, subgroup of phenolics, natural substances)

single intake of capsules with flavanols (subgroup of polyphenols, subgroup of phenolics, natural substances)

OTHER

Placebo

single intake of capsules with a placebo

Trial Locations (1)

9000

University of Ghent, Ghent

All Listed Sponsors
lead

University Ghent

OTHER

NCT03722199 - Effects of Flavanoids in Essential Hypertension, Type 2 Diabetes and Healthy Persons | Biotech Hunter | Biotech Hunter